Excessive reliance on molecular tests for Clostridium difficile infection, without testing for toxins and making a careful clinical assessment, is likely to result in overdiagnosis, overtreatment and excessive healthcare costs, a new study suggests. Researchers led by Dr Christopher Polage analysed the laboratory findings in 1,416 inpatients at the University of California Davis Medical Center ...
C. difficile: Treat the patient, not the test
By Tony James
24 Sep 2015